British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer

Post Reprod Health. 2019 Mar;25(1):21-32. doi: 10.1177/2053369118824920. Epub 2019 Feb 18.

Abstract

This guidance document by the British Menopause Society provides an overview of the management of women experiencing estrogen deficiency symptoms and arthralgia following a breast cancer diagnosis. It is now recommended that breast cancer patients are referred to health care professionals with an expertise in menopause for the management of such symptoms, which in turn often involves liaison with patients' breast cancer teams. However, as many women initially present to primary health care professionals for advice, this statement is aimed to support the latter in such consultations by providing information about symptom aetiology, current management strategies and controversies and identifying useful practice points.

Keywords: Arthralgia; breast cancer; menopause diagnosis; urogenital atrophy; vasomotor symptoms.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects*
  • Aromatase Inhibitors / adverse effects
  • Arthralgia / chemically induced
  • Arthralgia / therapy*
  • Atrophy / drug therapy
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / therapy*
  • Chemotherapy, Adjuvant / adverse effects
  • Consensus
  • Estrogens / deficiency*
  • Female
  • Hormone Replacement Therapy
  • Hot Flashes / therapy
  • Humans
  • Menopause, Premature*
  • Tamoxifen / adverse effects
  • Vagina / pathology
  • Vulva / pathology

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Estrogens
  • Tamoxifen